By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Novo Nordisk anticipates oral weight-loss drugs will capture one-third or more of the GLP-1 market by 2030, driven by ...

In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the ...

Nick Reiner's weight gain set him on a murderous path, but it didn't have to be that way ... just ask Dr. Drew.

Millions of Americans are using GLP-1s. But so far, there has been comparatively less research on what happens when users ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Dr. Drew Pinsky has weighed in on the disturbing case involving Nick Reiner and the brutal killings of his parents, Rob ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

Oral weight-loss drugs could make up a third or more of the overall GLP-1 market by 2030, a larger percentage than the ...